ATE490260T1 - Mit lipidmembran attachments verwandte oligonukleotide - Google Patents
Mit lipidmembran attachments verwandte oligonukleotideInfo
- Publication number
- ATE490260T1 ATE490260T1 AT05711148T AT05711148T ATE490260T1 AT E490260 T1 ATE490260 T1 AT E490260T1 AT 05711148 T AT05711148 T AT 05711148T AT 05711148 T AT05711148 T AT 05711148T AT E490260 T1 ATE490260 T1 AT E490260T1
- Authority
- AT
- Austria
- Prior art keywords
- strand
- lipid membrane
- oligonucleotide
- moieties
- hydrophobic anchoring
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54814904P | 2004-02-26 | 2004-02-26 | |
| PCT/SE2005/000288 WO2005082922A1 (en) | 2004-02-26 | 2005-02-28 | Oligonucleotides related to lipid membrane attachments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE490260T1 true ATE490260T1 (de) | 2010-12-15 |
Family
ID=34910990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05711148T ATE490260T1 (de) | 2004-02-26 | 2005-02-28 | Mit lipidmembran attachments verwandte oligonukleotide |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8389707B2 (de) |
| EP (1) | EP1718660B1 (de) |
| JP (2) | JP2007525500A (de) |
| AT (1) | ATE490260T1 (de) |
| AU (1) | AU2005217347A1 (de) |
| CA (1) | CA2558256C (de) |
| DE (1) | DE602005025087D1 (de) |
| DK (1) | DK1718660T3 (de) |
| NZ (1) | NZ549643A (de) |
| WO (1) | WO2005082922A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6706474B1 (en) | 2000-06-27 | 2004-03-16 | Board Of Trustees Of The University Of Illinois | Nucleic acid enzyme biosensors for ions |
| US6890719B2 (en) | 2002-05-10 | 2005-05-10 | The Board Of Trustess Of The University Of Illinois | Fluorescence based biosensor |
| NZ549643A (en) * | 2004-02-26 | 2009-07-31 | Layerlab Aktiebolag | Methods of forming lipid membrane attached linkers comprising contacting membrane with an oligonucleotide having two or more hydrophobic anchoring moieties |
| US7892734B2 (en) | 2005-08-11 | 2011-02-22 | The Board Of Trustees Of The University Of Illinois | Aptamer based colorimetric sensor systems |
| US7799554B2 (en) | 2006-03-16 | 2010-09-21 | The Board Of Trustees Of The University Of Illinois | Lateral flow devices |
| US8415461B2 (en) * | 2007-01-19 | 2013-04-09 | The Board Of Trustees Of The University Of Illinois | Amphiphilic substances and functionalized lipid vesicles including the same |
| WO2008089771A1 (en) * | 2007-01-24 | 2008-07-31 | Syddansk Universitet | Dna controlled assembly of lipid membranes |
| US8058415B2 (en) | 2007-04-24 | 2011-11-15 | The Board Of Trustees Of The University Of Illinois | Aptamer- and nucleic acid enzyme-based systems for simultaneous detection of multiple analytes |
| WO2010032945A2 (ko) * | 2008-09-16 | 2010-03-25 | 포항공과대학교 산학협력단 | 콜레스테롤을 이용한 생분자의 고정화 |
| US20100233270A1 (en) | 2009-01-08 | 2010-09-16 | Northwestern University | Delivery of Oligonucleotide-Functionalized Nanoparticles |
| AU2011207563B2 (en) | 2010-01-19 | 2016-03-10 | Northwestern University | Synthetic nanostructures including nucleic acids and/or other entities |
| US9650407B2 (en) * | 2011-11-02 | 2017-05-16 | The Regents Of The University Of California | Reprogramming of cellular adhesion |
| KR20140037716A (ko) * | 2012-09-19 | 2014-03-27 | 삼성전자주식회사 | 소포를 분리하기 위한 조성물, 키트 및 이를 이용하여 소포를 분리하는 방법 |
| AU2014270410B2 (en) * | 2013-05-24 | 2020-07-16 | Illumina Cambridge Limited | Pyrophosphorolytic sequencing |
| EP3024936B1 (de) | 2013-07-25 | 2019-09-04 | Exicure, Inc. | Sphärische nukleinsäurebasierte konstrukte als immunstimulatoren für prophylaktische und therapeutische verwendung |
| US10568898B2 (en) | 2013-08-13 | 2020-02-25 | Northwestern University | Lipophilic nanoparticles for drug delivery |
| US10182988B2 (en) | 2013-12-03 | 2019-01-22 | Northwestern University | Liposomal particles, methods of making same and uses thereof |
| TR201908550T4 (tr) | 2014-06-04 | 2019-07-22 | Exicure Inc | Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi. |
| US11213593B2 (en) | 2014-11-21 | 2022-01-04 | Northwestern University | Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
| US10967072B2 (en) | 2016-04-27 | 2021-04-06 | Northwestern University | Short interfering RNA templated lipoprotein particles (siRNA-TLP) |
| WO2018039629A2 (en) | 2016-08-25 | 2018-03-01 | Northwestern University | Micellar spherical nucleic acids from thermoresponsive, traceless templates |
| US11696954B2 (en) | 2017-04-28 | 2023-07-11 | Exicure Operating Company | Synthesis of spherical nucleic acids using lipophilic moieties |
| MX2020000387A (es) | 2017-07-13 | 2020-08-17 | Univ Northwestern | Método general y directo para preparar nanopartículas de estructura organometálica funcionalizadas con oligonucleotidos. |
| US12559787B2 (en) | 2018-05-21 | 2026-02-24 | The Regents Of The University Of California | Single cell mapping and transcriptome analysis |
| EP3818151A4 (de) * | 2018-07-06 | 2022-04-20 | The Regents of the University of California | Lipidmodifizierte oligonukleotide und verfahren zur verwendung davon |
| US11504425B2 (en) | 2019-02-26 | 2022-11-22 | Wayne State University | Amphiphilic oligodeoxynucleotide conjugates as adjuvant enhancers |
| US12319711B2 (en) | 2019-09-20 | 2025-06-03 | Northwestern University | Spherical nucleic acids with tailored and active protein coronae |
| JP7365022B2 (ja) * | 2019-10-28 | 2023-10-19 | 日本電信電話株式会社 | 生体分子の支持体とその製造方法 |
| US12378560B2 (en) | 2019-10-29 | 2025-08-05 | Northwestern University | Sequence multiplicity within spherical nucleic acids |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002033045A2 (en) * | 2000-10-12 | 2002-04-25 | The Public Health Research Institute Of The City Of New York, Inc. | Oligonucleotide - facilitated coalescence |
| EP1385997A2 (de) | 2001-04-09 | 2004-02-04 | Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.V. | System und methode zum nachweis und zur quantifizierung von nukleinsäuren unter verwendung kovalenter bindungen |
| WO2002081739A2 (en) | 2001-04-09 | 2002-10-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Non-enzymatic liposome-linked closely spaced array electrodes assay (nel-ela) for detecting and quantifying nucleic acids |
| AU2004275876B2 (en) * | 2003-09-25 | 2011-03-31 | Coley Pharmaceutical Gmbh | Nucleic acid-lipophilic conjugates |
| NZ549643A (en) * | 2004-02-26 | 2009-07-31 | Layerlab Aktiebolag | Methods of forming lipid membrane attached linkers comprising contacting membrane with an oligonucleotide having two or more hydrophobic anchoring moieties |
-
2005
- 2005-02-28 NZ NZ549643A patent/NZ549643A/en unknown
- 2005-02-28 AU AU2005217347A patent/AU2005217347A1/en not_active Abandoned
- 2005-02-28 WO PCT/SE2005/000288 patent/WO2005082922A1/en not_active Ceased
- 2005-02-28 DK DK05711148.6T patent/DK1718660T3/da active
- 2005-02-28 JP JP2007500723A patent/JP2007525500A/ja not_active Withdrawn
- 2005-02-28 AT AT05711148T patent/ATE490260T1/de active
- 2005-02-28 DE DE602005025087T patent/DE602005025087D1/de not_active Expired - Lifetime
- 2005-02-28 EP EP05711148A patent/EP1718660B1/de not_active Expired - Lifetime
- 2005-02-28 US US10/590,877 patent/US8389707B2/en not_active Expired - Fee Related
- 2005-02-28 CA CA2558256A patent/CA2558256C/en not_active Expired - Lifetime
-
2012
- 2012-10-04 JP JP2012222399A patent/JP2013055939A/ja active Pending
-
2013
- 2013-03-04 US US13/784,550 patent/US8901046B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NZ549643A (en) | 2009-07-31 |
| DK1718660T3 (da) | 2011-03-21 |
| EP1718660B1 (de) | 2010-12-01 |
| JP2007525500A (ja) | 2007-09-06 |
| WO2005082922A1 (en) | 2005-09-09 |
| US20070275047A1 (en) | 2007-11-29 |
| CA2558256C (en) | 2014-05-13 |
| CA2558256A1 (en) | 2005-09-09 |
| AU2005217347A1 (en) | 2005-09-09 |
| JP2013055939A (ja) | 2013-03-28 |
| US8901046B2 (en) | 2014-12-02 |
| DE602005025087D1 (de) | 2011-01-13 |
| EP1718660A1 (de) | 2006-11-08 |
| US8389707B2 (en) | 2013-03-05 |
| US20130252852A1 (en) | 2013-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE490260T1 (de) | Mit lipidmembran attachments verwandte oligonukleotide | |
| ATE546526T1 (de) | Hybrid-interferenz-rna | |
| ES2481040T3 (es) | Oligonucleótidos inmunoestimulantes | |
| TNSN07375A1 (fr) | Acides nucleiques de liaison a la ghreline | |
| WO2004015107A3 (en) | Further novel forms of interfering rna molecules | |
| BRPI0512110A (pt) | multìmeros de oligonucleotìdeos imunoestimulatórios | |
| EP2135950A3 (de) | Kurze interferierende Ribonukleinsäure (siRNA) zur oralen Verabreichung | |
| WO2004029212A3 (en) | In vivo gene silencing by chemically modified and stable sirna | |
| ATE479750T1 (de) | Ein system zur stabilen expression von sirnas in säugetierzellen | |
| WO2005030259A3 (en) | Nucleic acid-lipophilic conjugates | |
| WO2006073458A8 (en) | Oligonucleotides comprising a c5-modified pyrimidine | |
| EP2149538A3 (de) | Schnittstelleneingeleitete Nanorohrverbindung | |
| EP2294195A4 (de) | Oligonukleotid-duplexe mit dna-ähnlichen und rna-ähnlichen nukleotiden und verwendungen dafür | |
| EP2647711A3 (de) | Alternative Exportwege für über einen Vektor exprimierte RNA-Interferenz | |
| WO2006083800A3 (en) | Nucleic acid silencing of huntington's disease gene | |
| DK2135949T3 (da) | MCP-1-bindende nukleinsyrer | |
| MX2009000656A (es) | Acidos nucleicos que se fijan a sdf-i. | |
| WO2008092081A3 (en) | Targeted delivery of sirna | |
| ATE540110T1 (de) | Oligonukleotid-leiterkonstruktion und system zur erzeugung von molekularer vielfalt | |
| MX2007004686A (es) | Moleculas de arn de multidominio que comprenden al menos un aptamero para suministrar arn de doble hebra a organismos nocivos. | |
| ATE451981T1 (de) | Biegemaschine zur herstellung von käfigen für betonbauten | |
| EP0979309A4 (de) | Oligonukleotide mit verbesserter bioverfügbarkeit | |
| WO2006045591A3 (en) | Method and constructs for delivering double stranded rna to pest organisms | |
| WO2008001219A3 (en) | Cancer therapy using bcl-xl-specific sina | |
| MX377713B (es) | Moleculas de ácido ribonucleico pequeño de interferencia especifico de notch 1. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1718660 Country of ref document: EP |